Broad Institute takes three lines of attack in CRISPR appeal filing

The Broad Institute of Harvard and MIT has adopted three major arguments in its response to the University of California (UC), Berkeley’s appeal against a patent finding on the CRISPR technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Federal Circuit sides with Broad Institute in CRISPR clash

11 September 2018 The US Court of Appeals for the Federal Circuit handed a win to the Broad Institute of Harvard and MIT yesterday, after finding that the research institute is entitled to some patents covering CRISPR technology.

Africa

Clearing a way through the CRISPR patent jungle

8 May 2018 There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.

Americas

UC, Berkeley appeals to Federal Circuit in CRISPR patent clash

18 April 2017 The University of California, Berkeley and the University of Vienna have appealed against the Patent Trial and Appeal Board's decision in the dispute over CRISPR technology.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Broad Institute takes three lines of attack in CRISPR appeal filing

More on this story

Editor's picks

Editor's picks

More features